期刊文献+

姜黄素对非酒精性脂肪性肝病大鼠肝组织HO-1表达的影响 被引量:1

Effects of curcumin on expression of liver heme oxygenase-1 in non-alcoholic fatty liver disease rats
下载PDF
导出
摘要 目的观察姜黄素对高脂饮食诱导的非酒精性脂肪性肝病(NAFLD)大鼠肝组织血红蛋白氧合酶-1(HO-1)的影响。方法 SD大鼠36只随机分为正常组、模型组和姜黄素组(每组12只)。正常组全程饲以普通饲料,另两组均给予高脂饮食。于6周末每组各处死2只大鼠。验证NAFLD造模成功后,给予姜黄素组50 mg·kg-1·d-1姜黄素灌胃,正常组、模型组给予相应体积的0.5%羧甲基纤维素钠(CMC)灌胃。6周后,留取肝组织,免疫组织化学法测定肝组织HO-1的蛋白含量,荧光定量PCR法检测肝组织HO-1的mRNA表达。结果与正常组、模型组相比,姜黄素组大鼠肝组织内HO-1蛋白和mRNA表达均显著增高(P值均<0.01)。结论姜黄素可诱导NAFLD大鼠肝组织内HO-1的表达,可能是其防治NAFLD的机制之一。 Objective To observe the effects of curcumin on expression of liver heme oxygenase-1 in high-fat diet induced non-alcoholic fatty liver disease rats. Methods Thirty-six SD rats were randomly divided into the normal group, model group and curcumin group with twelve in each group. The rats in the normal group were fed with a standard diet while those in other two groups received a high-fat diet. Two rats from each group were executed at the end of the sixth week to detect the pathological changes. Then, the rats in the curcumin group were gavaged with 50 mg/kg of curcumin daily while those in the normal group and model group received an equal volume of 0.5% CMC as control. At the end of the twelfth week, all rats were executed. The protein and mRNA expressions of liver heine oxygenase-1 (HO-1) were determined by immunohistochemistry and RT-PCR. Results Compared with the normal group and model group, the protein and mRNA expressions of liver HO-1 were significantly higher in the curcumin group (P〈0.01). Conclusion Curcumin can induct the expression of liver HO-1, which may be one of its mechanisms for prevention and treatment of nonalcoholic steatohepatitis.
出处 《国际消化病杂志》 CAS 2013年第6期419-421,428,共4页 International Journal of Digestive Diseases
关键词 姜黄素 非酒精性脂肪性肝炎 大鼠 血红蛋白氧合酶-1 Curcumin Nonalcoholic steatohepatitis Rats Heme oxygenase-1
  • 相关文献

参考文献20

  • 1Marra F,Gastaldelli A,Svegliati Baroni G,et al.Molecularbasis and mechanisms of progression of non-alcoholicsteatohepatitis.Trends Mol Med,2008,14:72-81.
  • 2Malaguarnera L,Madeddu R,Palio E,et al.Heme oxygenase-1levels and oxidative stress-related parameters in non-alcoholicfatty liver disease patients.J-Hepatol,2005,42:585-591.
  • 3Abraham NG,Kappas A.Heme oxygenase and thecardiovascular-renal system.Free Radic Biol Med,2005,39:1-25.
  • 4Takahashi T,Shimizu H,Morimatsu H,et al.HemeOxygenase-1 is an Essential Cytoprotective Component inOxidative Tissue Injury Induced by Hemorrhagic Shock.J ClinBiochem Nutr,2009,44:28-40.
  • 5Haines DD,Lekli I,Teissier P,et al.Role of haemeoxygenase-1 in resolution of oxidative stress-relatedpathologies:focus on cardiovascular,lung,neurological andkidney disorders.Acta Physiol(Oxf)? 2012,204:487-501.
  • 6Hosick PA,Stec DE.Heme oxygenase,a novel target for thetreatment of hypertension and obesity? Am J Physiol RegulIntegr Comp Physiol,2012,302:R207-R214.
  • 7Bauer M,Bauer I.Heme oxygenase-1:redox regulation androle in the hepatic response to oxidative stress.Antioxid RedoxSignal,2002,4:749-758.
  • 8Iida A,Inagaki K,Miyazaki A,et al.Bachl deficiencyameliorates hepatic injury in a mouse model.Tohoku J ExpMed,2009,217:223-229.
  • 9Schmidt R,Tritschler E,Hoetzel A,et al.Heme oxygenase-1induction by the clinically used anesthetic isoflurane protects ratlivers from ischemia/reperfusion injury.Ann Surg,2007,245:931-942.
  • 10Yao P,Li K,Song F,et al.Heme oxygenase-1 upregulated byGinkgo biloba extract:potential protection against ethanol-induced oxidative liver damage.Food Chem Toxicol,2007,45:1333-1432.

二级参考文献4

共引文献12

同被引文献32

  • 1马晓燕,宫成军,付克模.肝脂消颗粒剂对脂肪肝大鼠脂蛋白代谢相关酶活性影响的实验研究[J].中国中医药科技,2006,13(6):391-392. 被引量:5
  • 2唐春萍,郭姣,杨超燕,何伟,袁安攀.调脂灵对高脂血症大鼠脂代谢酶及载脂蛋白的影响[J].广东药学院学报,2007,23(2):175-177. 被引量:15
  • 3VARELA R, MBAD E, ARIZ U, et al. Nonalcoholic steato-hepatitis and animal models: understanding the human dis-ease[J]. Int J Biochem Cell Biol, 2009,41 (5) : 969 -976.
  • 4ANGULO P, LINDOR KD. Nonalcoholic fatty liver disease[J]. JGastroenterol Hepatol, 2002, 17( Suppl) : 186 -190.
  • 5DEIVANAYAGAM S, MOHAMMED BS, VITOLA BE.et al.Nonalcoholic fattyliver disease is associated with hepatic andskeletal muscle insulin resistancein overweight adolescents[J]. Am J Clin Nutr, 2008, 88(6) : 180 -189.
  • 6KAMADA Y, TAKEHARA T,HAYASHI N. Adipocytokines andliver disease[J]. J Gastroenterol, 2008, 43 (11): 811 -822.
  • 7KASHI MR, TORRES DM, HARRISON SA. Current and e-merging therapies in nonalcoholic fatty liver disease[ J]. Se-min Liver Dis, 2008, 28(3) : 396 -406.
  • 8SALAMONE F, GALVANO F, MARINO GA. Silibinin improveshepatic and myocardial injury in mice with nonalcoholic steatohepatitis[J]. Dig Liver Dis, 2012, 41(15) : 334 -342.
  • 9SERVIDDIO G, SASTRE J,BELLANTI F, etal. Mitochondrialinvolvement in no- alcoholic steatohepatitis [ J ]. Mol As-pects Med, 2008, 29(3) : 22 -35.
  • 10PAN JL, WANG M, JI G, et al. The efficacyand safety of tra-ditional chinese( jiang zhi granule)for nonalcoholic fatty liver:a multicenter, randomized, placebo - controlled study [ J ].Evid Based Complement Alternat Med, 2013, 12(4) ; 719 -723.

引证文献1

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部